Dr. Sukari is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
31995 Northwestern Highway
Farmington, MI 48334Phone+1 800-527-6266Fax+1 313-576-8767- Is this information wrong?
Summary
- I am an Associate Professor in the department of Oncology, School of Medicine, Wayne State University. My main areas of interest are immuno-oncology, head and neck cancer and thoracic oncology. I am the head and neck multi-disciplinary team leader at Karmanos Cancer Institute (KCI) since 2014. I am a member of Eisenberg Center for Translational Therapeutics. I worked on multiple early development phase-I/transitional clinical trials in head and neck cancer, thoracic oncology and other solid tumors. During my 10 years at KCI, I published many publications, including peer to peer-reviewed original works, case reports, and abstracts. I was able to build a very busy oncology clinic at Karmanos Wertz clinic in Detroit and at Karmanos Weisberg in Farmington Hills, where I treat so many of my patients on therapeutic clinical trials. I play a crucial role in the Hem/Onc fellowship program and I was chosen the teacher of the year in 2016 by our fellows. I supervise so many of them in their continuity clinic and I mentored few fellows to complete their research projects, which resulted in multiple presentations in national and international oncology meetings as well as high quality publications. I received the Wayne State College teaching award in 2017.
I am ready to transition into a leadership position. My dream is to build a multi-disciplinary immuno-oncology/precision medicine program, with a focus on high quality research and a comprehensive oncology care.
Education & Training
- Beaumont Hospital, Royal OakFellowship, Medical Oncology, 2004 - 2006
- Beaumont Health (Royal Oak)Residency, Internal Medicine, 2001 - 2004
- University of Aleppo Faculty of MedicineClass of 1999
Certifications & Licensure
- MI State Medical License 2001 - 2027
- FL State Medical License 2014 - 2018
Clinical Trials
- Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer Start of enrollment: 2005 Jan 01
- T-cell Based Immunotherapy for Head and Neck Cancer Start of enrollment: 2009 Jun 01
- Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer Start of enrollment: 2010 Sep 09
- Join now to see all
Publications & Presentations
PubMed
- Molecular profiling and the impact of treatment on outcomes in adenoid cystic carcinoma (ACC) type-I and II.Grover, P., Elliott, A., McGrath, J., Xiu, J., Johnson, J., Hanna, G., Sukari, A., Wise-Draper, T.> ;Clinical Cancer Research. 2024 Feb 28
- 8 citationsBiomarkers predictive of response to pembrolizumab in head and neck cancer.David G Pfister, Robert I Haddad, Francis P Worden, Jared Weiss, Ranee Mehra, Laura Q M Chow, Stephen V Liu, Hyunseok Kang, Nabil F Saba, Lori J Wirth, Ammar Sukari, E...> ;Cancer Medicine. 2023 Mar 1
- 5 citationsSafety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.Charu Aggarwal, Nabil F Saba, Alain Algazi, Ammar Sukari, Tanguy Y Seiwert, Missak Haigentz, Mercedes Porosnicu, Marcelo Bonomi, Jean Boyer, Mark T Esser, Lily I Cheng...> ;Clinical Cancer Research. 2023 Feb 1
- Join now to see all
Journal Articles
- Role of F-BOX proteins in Cancer Cachexia and Muscle WastingA Sukari, I Muqbil, P Trilokia, PA Philip, A Azmi, Seminars in Cancer Biology, 1/1/2016
- Concurrent Chemoradiation Improves Survival in Hypopharyngeal CancerP.A. Paximadis, T. Kumar, G. Yoo, H.S. Lin, J. Jacobs, A. Sukari, Z. Kafri, W. Yoo, A. Konski, H. Kim, International Journal of Radiation Oncology*Biology*Physics, 1/1/2010
Books/Book Chapters
Abstracts/Posters
- Definitive concurrent chemoradiotherapy (CRT) for locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) using systemic dose carboplatin: A retrospec...M Nagasaka, M A. Zaki, M Issa, H E. Kim, J Abrams, A Sukari, Annual ASCO Meeting, 1/1/2016
- Preliminary results from KEYNOTE-055: Pembrolizumab after platinum and cetuximab failure in head and neck squamous cell carcinoma (HNSCC)J Bauml, T Y. Seiwert, D G. P fister, F P. Worden, S V. Liu, J Gilbert, N F. Saba, J Weiss, L J. Wirth, A Sukari, H Kang, M K. Gibson, E Massarelli, S F Powell, A Meis..., J Clin Oncol, 1/1/2016
- KEYNOTE-055: a phase 2 trial of single agent pembrolizumab in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) who have failed...S Powell, S Liu, A Sukari, C Chung, J Bauml, R Haddad, C Gause, M Niewood, L Gammage, H Brown, A Meister, J Cheng, M Gitau, Annual ASCO Meeting, 1/1/2015
- Join now to see all
Lectures
- How Can We Predict Who Will Respond to Checkpoint Inhibitors?Wayne State University - 1/19/2016
- The potential breakthrough in management of Head & Neck Cancers through checkpoint inhibitorsWayne State University - 1/15/2016
- The Future of Oncology; Cancer Immunotherapy in Head & Neck CancerPetoskey, MI - 1/14/2016
- Join now to see all
Authored Content
- Non-small cell to small cell lung cancer on PD-1 inhibitors: two cases on potential histologic transformationNovember 2018
Press Mentions
- Karmanos Cancer Institute Opens Medical Oncology Clinic in RosevilleJanuary 24th, 2023
- Karmanos Cancer Institute Opens Roseville Medical Oncology Clinic, Welcomes New OncologistJanuary 23rd, 2023
- TIL Therapy Takes Aim at Cervical CancerAugust 12th, 2019
- Join now to see all
Professional Memberships
- Member
Other Languages
- Arabic
Hospital Affiliations
- DMC Detroit Receiving Hospital & University Health CenterDetroit, Michigan
- DMC Harper University HospitalDetroit, Michigan
- Karmanos Cancer CenterDetroit, Michigan
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: